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Supplementary Figure 1 – Alignment of the DNA Binding Domain (DBD) of AtLFY, 
WelLFY and WelNDLY. 
 
  
Supplementary Figure 2 - Alignment of the predicted amino acid sequences of the five 
newly identified Welwitschia mirabilis genes reveals the conserved domain structure of 
MIKC-type MADS-box proteins. The yellow box indicates the MADS-domain and the 
orange box indicates the K-domain according to (Becker et al., 2000). The WelAG sequence 





Supplementary Figure 3 – Comparison of WelLFY and WelNDLY binding to 
individual sites from WelAP3/PI promoters. EMSA with 10 nM fluorescent DNA 
corresponding to the five sites indicated in Fig. 5C or AP1bs1 (used as a positive 
control) and 1 µM of WelLFYD (A) or WelNDLYD (B) in lanes 2-7. The relative 
intensities of the binding by WelLFY are slightly different as compared to the main 




Supplementary Figure 4 – Conservation of potential LEAFY binding sites in the 
promoters of conifer B genes. (A) Identification of potential LEAFY binding sites, using the 
WelLFYD matrix, in the 3.5kb upstream of the coding sequences of DAL13 from Picea abies 
and its homologs in Picea glauca (PgDAL13-1, PgDAL13-2), Pinus lambertiana (PlDAL13) 
and Pinus taeda (PtDAL13-1, PtDAL13-2). (B) Schematic representation of sites identified in 
(A). Sites that are species-specific are indicated with white boxes. Sites that are conserved 
between two or more species are depicted with the same coloured box. For each homolog, the 




Supplementary Table 1 – List of oligonucleotides used in this study. 
Oligonucleotides used to isolate Welwitschia genes 
Name Sequence  Name Sequence 
WelAG deg1F ATGGGMCGHGGVAARATYGA  WelBsis deg1F ATGGGHMGAGGMAARATHGA 
WelAG deg2F AACMGACARGTHACWTTYTG  WelBsis deg2F AAYAGRCARGTBACHTTYTC 
WelAG deg1R TCYTGWTGDGCRTARTGRTG  WelBsis deg1R TCYTGVAGRTTWGGYTGWGT 
WelB1 aF CCGAGAAATTGGATGCAAGC  WelB2 aF GTCATAGAGAGGTACAAGCAA 
WelB1 bF ACTGGATTAGAACCCTATGACGAC  WelB2 bF GATATGCAAAAAGAGAAAAATGAGAAT 
WelActinGeneF2 ATGGCCGATGCTGAGGACATTCAA  WelAGL6ATG-F ATGGGTCGAGGCAGAGTTGAACT 
WelActinGeneR2 CTAAAAGCACTTTCTGTGGACAATAG  WelAGL6StopR 
TCAGACTACCCATCCATGCATGT 
WelLFY-F GCGGGATCCTCAGGGATGGCTCCTGAAAGTT  WelNdly-F 
TAAAGCTTTCTGCATCCATGGTCG 




Oligonucleotides used for Semi-Quantitative RT-PCR 
Gene Oligonucleotide forward Oligonucleotide reverse Product size Name Sequence Name Sequence 
WelLFY WelLFYprobe2-F CGCAAGATCGATGAAAATG WelLFYprobe2-R 
GGAAACCCGCAAATC
CGCT 204 bp 
WelNDLY WelNdlyprobe2-F GGACTTGCAGAGGCTTGAAC WelNdlyprobe2-R 
ATCGCAGTTTCTTTGC
AGGT 179 bp 
WelAG ProbWelAG-F CGCTCTGCACAATCAACT WelAGprofil-R 
CCTGATGAGCATAGTG
ATGGGCA 340 bp 
WelAP3/PI-1 WelB1aF CCGAGAAATTGGATGCAAGC WelB1profil-R 
GTAAGTATTATTTTGA
AGGTTG 197 bp 
WelAP3/PI-2 WelB2bF GATATGCAAAAAGAGAAAAATGAGAAT ProbWelB2-R 
CTGAACGTTGGGTTGC
T 339 bp 
WelBsister ProbWelBsister-F GGAGCAGCAGCTGGAAACCGCAT ProbeWelBsister-R 
GGCTGAGTGGGTTGCA
G 299 bp 




TGCATG 271 bp 
WelActin WelActin-F TTGCAATTCAGGCAGTTTTG WelActin-R 
GGCCACATATGCCAAC
TTCT 260 bp 
 
Oligonucleotides used for in situ probe synthesis 
Gene Probe size 
PCR oligonucleotides 
Name Sequence (Sequence of T7 promoter in bold) 
WelLFY 291 bp WLFinsR CAAGTCTTTCCATGTAAGTCCT WLFinsLT7 TAATACGACTCACTATAGGGAGCCGAAAAGAAAAGGTTG 
WelNDLY 263 bp WNDinsR2 GTTTGTCCTCTGTTCATCACTGT WelfxT7 TAATACGACTCACTATAGGGACTTGCAGAGGCTTG 
WelAP3/PI-1 225 bp WelB1 aF CCGAGAAATTGGATGCAAGC ProbWelB1 RT7 TAATACGACTCACTATAGGGCCACTCTCTGAAAGAGT 
WelAP3/PI-2 339 bp WelB2 bF GATATGCAAAAAGAGAAAAATGAGAAT ProbWelB2 RT7 TAATACGACTCACTATAGGGCTGAACGTTGGGTTGCT 
WelAG 341 bp ProbWelAG F CGCTCTGCACAATCAACT ProbWelAG RT7 TAATACGACTCACTATAGGGCCTGATGAGCATAGTGAT 
 
Oligonucleotides used to construct expression plasmids 






























Oligonucleotides used in EMSA assays 
Name 5’-labeled TAMRA Non-fluorescent 
AP1bs1 TTGGGGAAGGACCAGTGGTCCGTACAATGT ACATTGTACGGACCACTGGTCCTTCCCCAA 
AGbs2 TGGATTTATACCCAATGTGTTAATGGGTTGT ACAACCCATTAACACATTGGGTATAAATCCA 
AP3bs1 CCTTCTTAAACCCTAGGGGTAATATTCTAT ATAGAATATTACCCCTAGGGTTTAAGAAGG 
 








Oligonucleotides used to synthesize the DNA sequences for SPR analysis 
Gene 5’-Biotin (Forward) Non-labelled (Reverse) 
WelAP3/PI-1 CGGATCTGGGTCGACTCTAGGCCT CCAGTCCACGCAAATAATCAGA 
WelAP3/PI-2 GTAAAACGACGGCCAG GGAGTTCTTGCTTAGAAGATCAC 
WelTubulin GGAAACAGCTATGACCATG AGTGAACAAATGCCCGCTTGG 
 
Supplementary Table 2 – B gene homologs identified in conifer species with sequenced 
genomes. The number of sites with scores > -20 in the 3.5kb upstream of the start codon is 
indicated. Best scores in upstream region of each gene are given to the right. Best scores 
across all B gene homologs within a species are indicated in white.  na = not assessed as 
sequence identified was incomplete at 3’ end. 	
Species Gene name Accession or Scaffold number 
Nb of sites with 
score > -20  Best score 
Picea abies DAL11 AF158539 4 -16.60 
 DAL12 AF15854 6 -16.69 
 DAL13 AF15843 9 -11.54 
Picea glauca PgDAL11-1 gb|ALWZ025600346.1 4 -18.24 
 PgDAL11-2 gb|ALWZ024195817.1 3 -16.60 
 PgDAL12-1 gb|ALWZ026117334.1 3 -16.69 
 PgDAL12-2 gb|ALWZ025965213.1 3 -16.69 
 PgDAL13-1 gb|ALWZ022140061.1 4 -12.67 
 PgDAL13-2 gb|ALWZ026682569.1 6 -12.67 
Pinus taeda PtDAL11 tscaffold8598 6 -15.95 
 PtDAL12 C32411524 na na 
 PtDAL13-1 tscaffold786067 13 -8.97 
 PtDAL13-2 tscaffold241828.2 8 -15.26 
Pinus lambertiana PlDAL11 scaffold1561304 13 7 -13.07 
 PlDAL12-1 scaffold489614 12 5 -18.30 
 PlDAL12-2 scaffold1694510 12 0 <-20 




Supplementary Table 3 – Size-exclusion chromatography assays with recombinant 
WelLFYDBD and WelNDLYDBD. 
 
 
Supplementary Table 4 – Position Weight Matrix (PWM) obtained for WelLFYD and 
AtLFYD. 
 WelLFYD   
 AtLFYD 
 A T C G   A T C G 
1 -2.43 0 -0.25 -0.48  1 -1.40 0 -0.92 -0.01 
2 0 -1.27 -3.61 -2.80  2 0 -2.45 -2.25 -1.44 
3 -2.59 0 -2.33 -3.21  3 -0.76 -1.63 -1.97 0 
4 
Lateral triplet 4-5-6 
 4 
Lateral triplet 4-5-6 5  5 
6  6 
7 -3.48 -4.46 0 -4.46  7 -2.31 0 -4.80 -3.85 
8 -4.68 -4.55 0 -4.55  8 -5.03 0 -5.14 -2.13 
9 
Central triplet 9-10-11 
 9 
Central triplet 9-10-11 10  10 
11  11 
12 -3.71 -4.68 -4.55 0  12 -2.13 -5.14 0 -5.03 
13 -4.39 -3.48 -4.46 0  13 -3.85 -4.80 0 -2.31 
14 
Lateral triplet 14-15-16 
 14 
Lateral triplet 14-15-16 15  15 
16  16 
17 0 -2.59 -3.21 -2.33  17 0 -1.97 -1.63 -0.76 
18 -1.27 0 -2.80 -3.61  18 -1.44 -2.25 -2.45 0 
19 0 -2.43 -0.48 -0.25  19 -0.01 -0.92 0 -1.40 
Lateral triplet 4-5-6 
  WelLFYD      AtLFYD   
  2nd position      2nd position   


























-4.99 -6.09 -5.68 -6.09 C  -3.55 -5.23 -4.01 -5.75 C 
-6.09 -6.09 -6.09 -6.09 G  -4.65 -6.15 -6.15 -5.75 G 
-6.09 -6.09 -5.17 -6.09 T  -3.62 -6.15 -4.07 -6.15 T 
C 
-6.09 -6.09 -4.58 -6.09 A  
C 
-4.54 -6.15 -3.41 -3.90 A 
-4.48 -6.09 -5.68 -6.09 C  -3.62 -6.15 -4.07 -6.15 C 
-6.09 -6.09 -5.68 -6.09 G  -5.75 -5.75 -6.15 -5.75 G 
-6.09 -6.09 -5.40 -6.09 T  -4.28 -6.15 -3.95 -5.05 T 
G 
-5.17 -5.17 -0.71 -3.89 A  
G 
-3.23 -5.75 -0.84 -2.95 A 
-3.79 -5.40 -3.56 -6.09 C  -3.06 -6.15 -3.62 -6.15 C 
-6.09 -6.09 -3.29 -5.68 G  -5.23 -6.15 -3.71 -6.15 G 
-5.40 -5.68 -3.29 -5.68 T  -3.32 -6.15 -2.84 -6.15 T 
T -2.32 -5.40 -2.36 -5.68 A  T -1.19 -5.46 -1.62 -4.28 A 
 Elution Vol. (ml) Equivalent MW (kDa) Predicted nb. of molecules 
 Assay 1 Assay 2 Assay 1 Assay 2 Assay 1 Assay 2 
WelLFYDBD 88.5 91.5 24.0 18.6 1.05 0.81 
WelNDLYDBD 91.5 90 18.6 21.1 0.82 0.93 
0 -3.14 -2.29 -3.65 C  0 -3.51 -1.94 -2.44 C 
-3.84 -6.09 -3.95 -6.09 G  -3.38 -5.75 -4.76 -5.75 G 
-1.22 -4.70 -1.14 -4.70 T  -1.50 -6.15 -1.53 -4.90 T 
 
Central Triplet 9-10-11 
  WelLFYD      AtLFYD   
  2nd position      2nd position   


























-1.03 -2.16 0 -2.42 C  -0.15 -1.12 0 -1.46 C 
-5.73 -4.48 -3.78 -5.73 G  -3.55 -3.27 -2.90 -4.65 G 
-3.78 -1.91 -1.91 -3.78 T  -2.13 -1.19 -1.19 -2.13 T 
C 
-5.73 -5.73 -5.73 -5.73 A  
C 
-4.94 -5.34 -5.34 -5.34 A 
-5.73 -4.23 -3.59 -5.04 C  -3.96 -2.30 -2.71 -3.74 C 
-5.73 -5.73 -5.73 -5.73 G  -4.65 -4.65 -4.65 -4.65 G 
-5.73 -3.78 -4.48 -5.73 T  -4.65 -2.90 -3.27 -3.55 T 
G 
-5.04 -3.20 -3.33 -5.04 A  
G 
-3.09 -2.90 -2.30 -3.96 A 
-3.86 -2.84 -2.84 -3.86 C  -1.88 -1.40 -1.40 -1.88 C 
-5.04 -3.59 -4.23 -5.73 G  -3.74 -2.71 -2.30 -3.96 G 
-2.42 0 -2.16 -1.03 T  -1.46 0 -1.12 -0.15 T 
T 
-5.73 -5.73 -5.73 -5.73 A  
T 
-4.94 -5.34 -5.34 -4.94 A 
-5.04 -3.33 -3.20 -5.04 C  -3.96 -2.30 -2.90 -3.09 C 
-5.73 -5.73 -5.73 -5.73 G  -5.34 -5.34 -5.34 -4.94 G 
-5.73 -3.94 -5.73 -5.73 T  -4.43 -3.47 -3.84 -3.74 T 
 
Lateral Triplet 14-15-16 
  WelLFYD      AtLFYD   
  2nd position      2nd position   


























-5.68 -3.29 -5.68 -5.40 C  -6.15 -2.84 -6.15 -3.32 C 
-6.09 -5.40 -6.09 -6.09 G  -5.05 -3.95 -6.15 -4.28 G 
-6.09 -5.17 -6.09 -6.09 T  -6.15 -4.07 -6.15 -3.62 T 
C 
-6.09 -3.95 -6.09 -3.84 A  
C 
-5.75 -4.76 -5.75 -3.38 A 
-5.68 -3.29 -6.09 -6.09 C  -6.15 -3.71 -6.15 -5.23 C 
-6.09 -5.68 -6.09 -6.09 G  -5.75 -6.15 -5.75 -5.75 G 
-6.09 -6.09 -6.09 -6.09 T  -5.75 -6.15 -6.15 -4.65 T 
G 
-3.65 -2.29 -3.14 0 A  
G 
-3.44 -1.94 -3.51 0 A 
-6.09 -3.56 -5.40 -3.79 C  -6.15 -3.62 -6.15 -3.06 C 
-6.09 -5.68 -6.09 -4.48 G  -6.15 -4.07 -6.15 -3.62 G 
-6.09 -5.68 -6.09 -4.99 T  -5.75 -4.01 -5.23 -3.55 T 
T 
-5.68 -2.36 -5.40 -2.32 A  
T 
-4.28 -1.62 -5.46 -1.19 A 
-3.89 -0.71 -5.17 -5.17 C  -2.95 -0.84 -5.75 -3.23 C 
-6.09 -4.58 -6.09 -6.09 G  -3.90 -3.41 -6.15 -4.54 G 
-6.09 -3.12 -6.09 -5.68 T  -4.36 -1.45 -6.15 -3.29 T 
 
Supplementary Table 5 – Examples of sequences (chosen from the 100 most frequent 
sequences) isolated in the SELEX-seq assays performed with WelNDLYD. Eighteen 
sequences clearly resembling those bound by AtLFYDBD are highlighted in blue, while the 
majority of sequences (in yellow) are very different (score < -20). 
Sequence ID Sequence Score calculated with AtLFYDBD Matrix 
WelNDLY-NC 19 TATTACCCAGTGGATAATAGTTCTCTAGAT -2,31 
WelNDLY-NC 1 CCAGCGCAGGATTACCCAGCGGTCCATGCT -2,58 
WelNDLY-NC 97 AGGTCGCATGGACCGATGGGTAATAGCGTC -3,25 
WelNDLY-NC 13 GTTTATCCGTTGGGTAATAGCTCTCTAGAT -3,94 
WelNDLY-NC 2 TTTTACCCAGCGGACAATCAATGGGTGTAT -4,39 
WelNDLY-NC 73 AACTACGGACCGCTGGGTAAAGGCGTGGTC -4,41 
WelNDLY-NC 7 TCTTGTTGGGCATTGTCCGCTGGGTAAAGA -4,51 
WelNDLY-NC 74 TCTTGTTGGGCATTGTCCGCTGGGTAAAGA -4,51 
WelNDLY-NC 80 CGTTATCCAGCGGGTAATAGGGGGGGAGAC -4,59 
WelNDLY-NC 23 TTTGAGTATTACCCGTTGGTTAACAGCCAA -4,89 
WelNDLY-NC 65 AATGGTGCTAGACGGACCGCTGGGTAATCG -4,96 
WelNDLY-NC 67 GATGGACCGATGGATAATATCCGTGTCGCT -4,98 
WelNDLY-NC 18 TAGTGCATAGACCGTTGGGTAATGACCGCA -5,04 
WelNDLY-NC 43 AGTGTGCAATTGTCCAGCGGTTAATAAGGG -5,68 
WelNDLY-NC 77 CCAGCGCAGGATTACCCAGCGGGCCATGCT -6,61 
WelNDLY-NC 78 CCAACGGTTATTGCCCGGTGGTCCTTACGC -7,05 
WelNDLY-NC 45 CAAACGAGGGGACGGACCGCTGGATAACGA -8,35 
WelNDLY-NC 55 ATATGCTTCGGACCGACGGTTAATAGCGGA -9,21 
WelNDLY-NC 85 ACGTTCAGGTACACAGTAGTTACAACATC -20,79 
WelNDLY-NC 53 TGTTCGCCGGGGCTATGTCCGAGGTTGTAAG -21,17 
WelNDLY-NC 87 AATAACGGAAGGCTGGAACGTTTCAGCCAA -21,84 
WelNDLY-NC 63 TTTGTGCCGCTGAATCGATTCCGTAGCTGT -22,22 
WelNDLY-NC 91 TGATGCTACGCCGAGCAGAACCTTGGGACA -22,40 
WelNDLY-NC 21 TGATATACCAAGTCTAATGCATAGGTCTCT -22,58 
WelNDLY-NC 22 TGATATACCAAGTCTAATGCATAGGTCTCT -22,58 
WelNDLY-NC 54 GTGATATACCAAGTCTAATGCATAGGTCTC -22,58 
WelNDLY-NC 86 GTGCCATCTAAGAGTCCGATGTTGTAACTA -22,88 
WelNDLY-NC 39 ACCTTTAGTCCGCAGGCAGCGGTCCGGAT -23,13 




WelNDLY-NC 41 GTTATAACGTTCGTTAGGGCCTCCCCTACTC -23,59 
WelNDLY-NC 44 GTTATAACGTTCGTTAGGGCCTCCTTCAGAT -23,59 
WelNDLY-NC 68 GTTATAACGTTCGTTAGGGCCTCCTCTGGAT -23,59 
WelNDLY-NC 72 TTCGTCGTTGGAACAACTCGTTAGAATTGC -24,37 
WelNDLY-NC 95 TGAATCGATTTAGTCGGACACAGGGTTGTG -24,90 
WelNDLY-NC 90 AAGATTGTAGCAAGCGTTAAATTGCCGTCT -25,45 
WelNDLY-NC 5 TGACCGCTGTGTAATAAGATGGTCTAGAG -25,51 
WelNDLY-NC 42 TGACCGCTGTGTAATAAGATGGTCTAGAT -25,51 
WelNDLY-NC 69 TATCCGAGAGGCTCAGCCCGTGGCACGACA -25,51 
WelNDLY-NC 31 TGGACCATGTCGCCAAGTTCGTTAATGTCAA -25,53 
WelNDLY-NC 30 TAACAAGACACCTGCCAGTTTTCGTAACAT -25,65 
WelNDLY-NC 38 TAACAAGACACCTGCCAGCTTTCGTACCAT -25,74 
WelNDLY-NC 94 ACACCCCTACCAAGGTTAGTTACAACATCG -25,82 
WelNDLY-NC 70 TTATCGCGGCCTGATGTATGTTGTAACTAT -26,07 
WelNDLY-NC 28 CGCGTTATAACGTTCGTTAGGGCCTCCTTC -26,08 
WelNDLY-NC 36 CGCGTTATAACGTTCGTTAGGGCCTCCCCT -26,08 
WelNDLY-NC 58 CGCGTTATAACGTTCGTTAGGGCCTCCTCT -26,08 
WelNDLY-NC 61 CGCGTTATAACGTTCGTTAGGGCCTCCCCT -26,08 
WelNDLY-NC 12 TTTTGCTCATCGCTGCTATGGGCATGAACT -26,09 
W12 CGCAAGATGCTGTACCGATTCGGCCGCAAC -26,23 
WelNDLY-NC 71 ATGTAAGCGTCGTGTTGAATCGTTTCAGTT -26,33 
WelNDLY-NC 66 AATTAGCAGATGGGTGCAAAATCGATTCAG -26,36 
WelNDLY-NC 75 AGTTACCCTAACGAGCTCTTAGCGACGGGC -26,39 
WelNDLY-NC 82 TGACCGCTGGGTAAAGACGGAGGAGGCATGT -26,39 
WelNDLY-NC 46 TTGCTGTAGCACGGTGGGAACGTTCCCGTTT -26,51 
WelNDLY-NC 3 TAACAAGACACCTGCCAGTTTTCGTACCAT -26,85 
WelNDLY-NC 4 TAACAAGACACCTGCCAGTTTTCGTACCAT -26,85 
WelNDLY-NC 6 GGATAACAAGACACCTGCCAGTTTTCGTAC -26,85 
WelNDLY-NC 10 GATAACAAGACACCTGCCAGTTTTCGTACC -26,85 
WelNDLY-NC 14 TAACAAGACACCTGCCAGTTTTCGTACCAT -26,85 
WelNDLY-NC 24 GATAACAAGACACCTGCCAGTTTTCGTACC -26,85 
WelNDLY-NC 83 ATAACAAGACACCTTCCAGTTTTCGTACCA -26,85 
WelNDLY-NC 49 TGACCGCTGGTCAATATCCACTTCGTGAGTC -26,93 
WelNDLY-NC 64 GTGCTGACGGAGGACACGTGTTAGGTAAGAA -26,94 
WelNDLY-NC 9 CTCATCGCTGCTATGGGCATGAACTCTAGAT -27,40 
WelNDLY-NC 17 GCTCATCGCTGCTATGGGCATGAACTCTAG -27,40 
WelNDLY-NC 20 TTGCTCATCGCTGCTATGGGCATGAACTCTA -27,40 
WelNDLY-NC 33 GCTCATCGCTGCTATGGGCATGAACTCTAG -27,40 
WelNDLY-NC 35 CTCATCGCTGCTATGGGCATGAACTCTAGAC -27,40 
WelNDLY-NC 62 TCATCGCTGCTATGGGCATGAACTCTAGAC -27,40 
WelNDLY-NC 59 ACGGACGATGGCAGATGGATGTTGTAACTA -27,42 
WelNDLY-NC 60 GTCGACCTGCTTATCTGTACTCACTCCTCT -27,54 
WelNDLY-NC 52 ATGCTCGTTAGCGTTAACGCGTCGCATATC -27,92 
WelNDLY-NC 32 GCTCATCGCTGCTATGGGCATGGACTCTAG -28,06 
WelNDLY-NC 56 CTCATCGCTGCTATGGGCATGGACTCTAGA -28,06 
WelNDLY-NC 48 GACCACGAACGGCTTTGTATGTTGTAACTA -28,12 
WelNDLY-NC 96 TAACAAGACACCTGCCAGTTTTCGCACCAT -28,17 
WelNDLY-NC 15 AGTCGACCTGCTTATCTGTGCTCACTCCTCT -28,20 
WelNDLY-NC 25 GAGTCGACCTGCTTATCTGTGCTCACTCCTCT -28,20 
WelNDLY-NC 26 GAGTCGACCTGCTTATCTGTGCTCACTC -28,20 
WelNDLY-NC 50 AGTCGACCTGCTTATCTGTGCTCACTCCTCT -28,20 
WelNDLY-NC 81 GAGTCGACCTGCTTATCTGTGCTCACTCCTC -28,20 
WelNDLY-NC 84 GTCGACCTGCTTATCTGTGCTCACTCCTCT -28,20 
WelNDLY-NC 40 TGAATCGTTACAGCAGCACGGGCGGTCAAA -28,27 
WelNDLY-NC 27 CGACCTGCTTATCTATGCTCACTCCTCTGG -29,13 
WelNDLY-NC 76 ATGGGCCACATGCAAAATCGTTTCAGCACT -29,13 
WelNDLY-NC 92 ACTAACGCATTGGGATCGTTCCCCCTGTGT -29,43 
WelNDLY-NC 89 GACAGGGGATAGCCGAATCGTTTCAGCGTC -29,98 
W10 CGCAAGATGCTGAACCGCTCCAGCCGCAAC -30,41 
WelNDLY-NC 29 TGTCCGCTGGGTAATAGTGCACCTCCAACTC -30,85 
WelNDLY-NC 93 TAACAAGACACCTGCCAGGTTTCGTACCAT -30,94 
WelNDLY-NC 88 CATACGAAGACACGTGACGAATCGATTCAG -31,51 
WelNDLY-NC 51 TTTGCTGAATCGTTTCTGCGCCCTCCGAAC -32,20 
  
Supplementary Methods 
Isolation of Welwitschia sequences and phylogenetic analyses 
Total RNAs were extracted with TRIzol reagent (Invitrogen) from leaves or dissected cones. 
For each sample, 2 µg of total RNA was treated with RNAse-free DNAse (Ambion) and 
quantified using a NanoDrop-ND100 (NanoDrop Technologies). cDNA was synthesized from 
1 µg of total RNA with the RevertAid M-MuLV RT (Fermentas), using oligo-dT primers. 
WelAG (KF145186), WelAP3/PI-1 (KF145184), WelAP3/PI-2 (KF145185) and WelBsister 
(KF145187) were isolated using degenerate primers (see SI Table 5) and 3’ and 5’ RACE kits 
(Invitrogen). The sequences of P. abies actin (ACP1972) and G. gnemon AGL6 (GGM13, 
CAB44459) were used as query for a BLAST search against a Welwitschia EST database 
(Albert et al., 2005). EST contig assembly was performed with DNA BASER Sequence 
Assembler 2.6 and the complete coding sequences of WelActin and WelAGL6 (KF145188) 
were subsequently obtained by PCR using cDNA from mixed cones as template, PhusionÒ 
DNA polymerase (Ozyme) and specific primers (see SI Table 5). Phylogenetic placement was 
evaluated using three different methods. First, our Welwitschia and GenBank Gnetum gnemon 
and G. parvifolium MADS-box amino acid sequences (CAB44448, CAB44449, CAB44455, 
CAB44457, CAB44459, CAC13991, CAC13992, CAC13993, BAA85629, BAA85630, 
BAA85631) were aligned with MUSCLE 3.6 using default settings (Edgar, 2004) and the 
nucleotide sequences were then force-aligned based on the amino acid alignment using 
PAL2NAL (Suyama et al., 2006). Poorly aligned regions were removed, third codon positions 
were down weighted, and 1000 parsimony bootstraps were performed using PAUP* 4.0, and 
using amino acid characters with a Blosum62 derived stepmatrix (Hill et al., 2006). A second 
phylogenetic analysis was performed from the amino acid alignment of MADS genes from 
(Winter et al., 2002). The Welwitschia genes were added by hand, and 1000 neighbour-
joining bootstraps were performed using PAUP* 4.0, with a character weight matrix based on 
the Blosum62 matrix.  In our third phylogenetic analysis, the alignment from Becker and 
Theissen (Becker & Theißen, 2003), with added Welwitschia and Gnetum genes (except 
GGM17) was analyzed within SeaView 4.3.0 (Gouy et al., 2010). First it was degapped and 
realigned by MUSCLE, then a tree was calculated by PhyML with branch support evaluated 
by the approximate likelihood ratio test (aLRT).  The model used was blosum62; otherwise 
defaults were used. 
 
Semi-quantitative RT-PCR 
PCR reactions were carried out in 50 µl using cDNA derived from 50 ng of DNAse-treated 
total RNA as template. 5 µl were taken after 25, 30 and 35 cycles and visualized on 2% 
agarose gels stained with SYBR®Safe (Invitrogen). A fragment of Welwitschia actin cDNA 
was amplified as a control under the same conditions but samples were taken after 20, 25 and 
30 cycles. Primer combinations used are given in SI Table 5. 
 
In situ hybridization 
Following a fixation step in 4% paraformaldehyde, tissues were dehydrated and progressively 
embedded in Paraplast X-Tra™ (Tyco/Healthcare). Embedded cones were cut at 7 µm thick 
and sections mounted on polylysine coated glass slides (ProbeOn Plus, Fisher Biotech). Wax 
removal, proteinase K treatment (Invitrogen), paraformaldehyde fixation and probe 
hybridization were performed according to the J. Long protocol 
(www.its.caltech.edu/~plantlab/protocols/insitu.pdf). Probes were designed against the most 
specific region of each gene of interest: for WelLFY and WelNDLY, a probe corresponding to 
the variable sequence spanning exons 1 and 2 of each gene was amplified. For Welwitschia 
MADS-box genes, a probe matching the characteristic C-terminal end of each gene was used. 
Probes were synthesized according to (Drea et al., 2005): cDNA corresponding to 
WelAP3/PI-1, WelAP3/PI-2 and WelAG cloned in pCR2.1 vectors (Invitrogen), pEDW84 or 
pEDW87 were used as templates in PCR reactions with GoTaq DNA polymerase (Promega) 
and the primers given in SI Table 5. The PCR products obtained were used as templates for 
the in vitro transcription step with DIG RNA Labelling Kit (Roche) according to the 
manufacturer’s instructions. Probe quality and concentration were checked with a 
BioAnalyzer 2100 (Agilent). The Frohlich and Moyroud illumination method (Frohlich & 
Moyroud, 2008) was used to minimize the effects of light scattering that can make dense 
tissues appear dark. Multiple in situ hybridization attempts with female cones were 
unsuccessful. 
 
Expression plasmid construction 
WelLFYDBD and WelNDLYDBD expression plasmids. 
Residues 247-411 from WelLFY cDNA (AF109130) and residues 245-407 from WelNDLY 
cDNA (AF108227) were amplified with PhusionÒ DNA polymerase (Ozyme) and primers 
given in SI Table 5, subcloned into pCR-Blunt (Invitrogen) and shuttled to pETM-11 
(Dümmler et al., 2005) as NcoI/XhoI fragments to yield the pFLO3 and pFLO4 expression 
vectors. 
GFP-WelNDLYDBD expression plasmid. 
A GFP fragment was amplified from pBS-GLFY plasmid obtained from X. Wu (Wu et al., 
2003) using primers oETH1001 and oETH1002. This fragment was subsequently used as a 
megaprimer to amplify plasmid pFLO4 and yield pETH25. 
AtLFYD, WelLFYD and WelNDLYD expression plasmids. 
Residues 40-424 from AtLFY cDNA (AAM27940), residues 58-411 from WelLFY cDNA and 
residues 56-407 from WelNDLY cDNA were amplified with PhusionÒ DNA polymerase 
(Ozyme) and primers given in SI Table 5, subcloned into pCR-Blunt (Invitrogen) and shuttled 
to pETM-30a+ as a NdeI/XhoI fragment to yield the pETH79, pEDW29 and pEDW49 
expression vectors. 
 
Protein expression and purification 
pFLO3 and pFLO4 vectors were used to produce recombinant WelLFYDBD and WelNDLYDBD 
proteins according to the protocol previously described for LFYDBD from A. thaliana (Hamès 
et al., 2008). AtLFYD, WelLFYD and WelNDLYD were expressed using Escherichia coli 
strain Rosetta™ 2(DE3)pLys (Novagen) transformed with pETH79, pEDW29 or pEDW49 
respectively. After induction by 0.5 mM IPTG, cells were grown overnight at 17°C. The 
pellet from a 1 l culture was sonicated in 50 ml lysis buffer (50 mM Tris-HCl pH8, 5 mM 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) with one protease inhibitor cocktail 
table Complete EDTA-free (Roche) and centrifuged for 45 minutes at 16500 rpm. The 
supernatant was loaded on a column with 1 ml Ni-NTA resin (Qiagen), then washed with 35 
ml of wash buffer (50 mM Tris-HCl pH8, 20 mM imidazole, 5 mM TCEP) and eluted with 
the same buffer containing 350 mM imidazole. The fractions containing the protein were 
pooled and dialysed overnight in 50 mM Tris-HCl pH8, 5 mM TCEP buffer at 4°C. Next, the 
proteins were exposed to a salt shock with 0.8 M NaCl to remove the bacterial DNA bound to 
the proteins and the Ni-NTA purification step was repeated as previously except that 0.8 M 
NaCl was added to the wash and elution buffers. The fractions containing the proteins were 
pooled and applied to a Hi-load Superdex-200 16/60 prep grade column (GE Healthcare) 
equilibrated with 20 mM Tris-HCl pH8, 0.8 M NaCl and 5 mM TCEP to eliminate aggregated 
protein by size exclusion chromatography. 
 
EMSA assay 
The double stranded DNA probes used (Fig. 4A-C) were generated by annealing single-
stranded oligonucleotides, 5’-labeled with TAMRA (Sigma), to non-fluorescent 
complementary oligonucleotides in annealing buffer (10 nM Tris pH7.5, 150 mM NaCl and 1 
mM EDTA). The corresponding sequences are listed in SI Table 5. For each reaction, 10 nM 
fluorescent dsDNA was incubated with the protein in 20 µl binding buffer (20 mM Tris–HCl 
pH 7.5, 150 mM NaCl, 1% glycerol, 0.25 mM EDTA, 2 mM MgCl2, 28 ng/ml fish sperm 
DNA (Roche) and 3 mM DTT). For Fig. 4D and Fig. 5D, DNA probes were generated by 
annealing single-stranded oligonucleotides (with a protruding G on one end) in annealing 
buffer (10 nM Tris pH7.5, 150 mM NaCl and 1 mM EDTA). Labelling of 4 pmol dsDNA was 
then performed by end-filling using 8 pmol Cy3-dCTP and 1 U of Klenow fragment for 1 h at 
37 °C, followed by enzyme inactivation at 65 °C for 10 min. For each reaction, 10 nM 
fluorescent dsDNA was incubated with the protein in 20 µl binding buffer (10 mM Hepes pH 
7.5, 1 mM spermidine, 1% glycerol, 14 mM EDTA pH 8, 0.3 mg/ml BSA, 0.25 % CHAPS, 
28 ng/ml fish sperm DNA (Roche) and 3 mM TCEP). After 15 min incubation on ice, binding 
reactions were loaded onto native 6% polyacrylamide gels 0.5X TBE and electrophoresed at 
90 V for 90 min at 4°C. Gels were scanned on a Typhoon 9400 scanner (Molecular 
Dynamics, Sunnyvale, CA). 
 
Cloning of WelAP3/PI-1 and WelAP3/PI-2 upstream sequences and WelTubulin genomic locus 
A 32P labelled DNA probe corresponding to the WelAP3/PI-1 and WelAP3/PI-2 PCR products 
(see in situ hybridization) was used to probe four lambda genomic sublibraries as in (Frohlich 
& Meyerowitz, 1997). The upstream sequences of the two corresponding genes were retrieved 
by PCR with PhusionÒ DNA polymerase (Ozyme), using the selected lambda phage plaques 
as templates and primer Lambda786 matching within the lambda vector and the gene-specific 
primer WelB1screenR2 or WelB2screenR3 (see SI Table 5). Both PCR fragments were 
cloned in pCR-Blunt to yield the new vectors pEDW131 and pEDW130, containing the 
WelAP3/PI-1 or WelAP3/PI-2 upstream sequence respectively (KF145189, KF145190). The 
WelTubulin sequence was identified using the Picea wilsonii tubulin sequence (ABX57816) 
to perform a BLAST search against a Welwitschia EST database (Albert et al., 2005). The 
WelTubulin genomic locus was amplified with PhusionÒ DNA polymerase (Ozyme) using 
genomic DNA as a template and the primers oEDW-WelTubulin-gene-F1 and oEDW-
WelTubulin-gene-R1 (see SI Table 5). The fragment obtained was cloned in pCR-Blunt to 
yield the vector pEDW64. 
 
SPR analysis of DNA-protein interaction 
Double-stranded DNA molecules for SPR analysis were synthesized by PCR amplification 
from pEDW131, pEDW130 and pEDW64 plasmids using the primers listed in SI Table 5. 
PCR products were purified using a NucleoSpin® Extract II kit (Macherey-Nagel) and 
quantified with a NanoDrop-ND100 (NanoDrop Technologies). Chip immobilisation and 
sensogram recording were performed according to (Moyroud et al., 2009). Real-time SPR 
interaction curves were analysed using the BiacoreT100 analysis software. For each analysis, 
the response of the reference channel was subtracted from the interaction curves obtained 
from the 3 experimental channels. These normalized curves were fitted globally to a 
heterogeneous ligand interaction model, permitting the determination of two apparent 
dissociation constants (KDApp), corresponding to the presence of two types of binding sites. 
The validity of the interaction model was verified by data fitting (c2<10). KDApp values in the 
nM range were considered as indicative of high affinity binding events, while KDApp values in 
the uM range were regarded as low affinity interactions (Moyroud et al., 2009). 
 
Identification of WelLFY binding sites in WelAP3/PI-1, WelAP3/PI-2 and in conifer homologs of 
DAL11, 12 and 13 upstream sequences 
The predicted affinity of every possible 19-mer within WelAP3/PI-1, WelAP3/PI-2 and 
conifer homologs of DAL11, DAL12 and DAL13 upstream sequences was calculated as 
previously described (Moyroud et al., 2011) using WelLFYD PWM as a model and 
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